5-methylcytosine has been researched along with Carcinoma, Pancreatic Ductal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, Q; Fan, S; Jiang, K; Liu, J; Shen, P; Wu, P; Xiao, B; Yang, T; Yuan, H; Zhao, L | 1 |
| Achreja, A; Agarwal, B; Aluri, S; Baddour, J; Banerjee, D; Bartenstein, M; Batra, S; Bhagat, P; Bhagat, TD; Bhattacharyya, S; Choudhary, GS; Dawlaty, M; Giricz, O; Goggins, M; Gordon-Mitchell, S; Greally, J; Guerrero, PA; Gupta, S; Kwak, C; Maitra, A; Nagrath, D; Patel, B; Pradhan, K; Sahu, S; Sohal, D; Steidl, U; Suzuki, M; Verma, A; Von Ahrens, D; Yang, L; Yu, Y; Zhao, H; Zou, Y | 1 |
| Chen, L; Cui, H; Li, W; Liu, J; Liu, Y; Luo, F; Luo, Z; Song, H; Zheng, W | 1 |
| Cao, F; Guo, Z; He, Y; Hu, X; Li, A; Liu, H; Tu, K; Wei, A; Xia, L; Xie, D; Yuan, J; Zhang, J | 1 |
| Alruwaii, ZI; Ding, D; Fujikura, K; Goggins, MG; Haffner, MC; He, J; Hong, SM; Hruban, RH; Macgregor-Das, A; Meeker, AK; Roberts, NJ; Roy, S; Trujillo, MA; Wood, LD; Wright, M | 1 |
| Abraham, AG; Blake, A; Blancher, C; Burns, A; D'Costa, Z; Eyres, M; Goldin, R; Hubert, A; Hughes, D; Hughes, S; Jones, S; Lanfredini, S; Maughan, T; Mukherjee, S; O'Neill, E; Sabbagh, A; Schuh, A; Silva, M; Soonawalla, Z; Thapa, A; Vavoulis, D; Verrill, C; Willenbrock, F; Xu, H | 1 |
6 other study(ies) available for 5-methylcytosine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
Topics: 5-Methylcytosine; Carcinoma, Pancreatic Ductal; Humans; Pancreatic Neoplasms; Prognosis; Risk Factors; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; Tumor Microenvironment | 2021 |
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
Topics: 5-Methylcytosine; Animals; Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cellular Reprogramming; DNA Methylation; Epigenesis, Genetic; Humans; Ketoglutaric Acids; Lactic Acid; Mesenchymal Stem Cells; Mice; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptors, CXCR4; Stromal Cells; Transcriptome | 2019 |
PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
Topics: 5-Methylcytosine; Ascorbic Acid; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Prognosis; Promoter Regions, Genetic; Sodium-Coupled Vitamin C Transporters; Survival Analysis; Up-Regulation | 2020 |
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
Topics: 5-Methylcytosine; Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell-Free Nucleic Acids; Epigenesis, Genetic; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2020 |
Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Carcinogenesis; Carcinoma, Pancreatic Ductal; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mixed Function Oxygenases; Pancreatic Neoplasms; Proto-Oncogene Proteins | 2021 |
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Topics: 5-Methylcytosine; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Epigenome; Epigenomics; GATA6 Transcription Factor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Metformin; Mice, Nude; Mice, Transgenic; Pancreatic Neoplasms; Retrospective Studies; Smad4 Protein; Transcription, Genetic; Transcriptome; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |